Latest Chinese Drug Coverage Comes With Steep Price Cuts, Caveats
But Bigger Volumes Await
Executive Summary
November negotiations in China over the prices of 67 new drugs have resulted in record price cuts, averaging around 62% overall and 65% for anti-tumor products. But the sting is alleviated by the prospect of substantial volume increases.